Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

A trial has shown boosting diet with supplements could halt tumour growth in prostate cancer patients - opening the door to a ...

Prostate Cancer Progress: Novel Immunotherapy Agent Enoblituzumab Shows Potential in Clinical Trials for High-Risk Patients NEW YORK, NY, USA, June 22, 2023 ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

The Prostate Cancer Foundation (PCF) today announced that Howard R. Soule, Ph.D., will retire as PCF’s Chief Science Officer, ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...